Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study

Background: The effect of sacubitril/valsartan on survival and hospitalization risk in older patients with heart failure has not been explored. We aimed to investigate the risk of hospitalization and mortality with the use of sacubitril/valsartan vs. enalapril in patients with heart failure.Methods:...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Swathi Pathadka, Vincent K. C. Yan, Xue Li, Gary Tse, Eric Y. F. Wan, Hayden Lau, Wallis C. Y. Lau, David C. W. Siu, Esther W. Chan, Ian C. K. Wong
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2021-01-01
Цуврал:	Frontiers in Cardiovascular Medicine
Нөхцлүүд:	heart failure sacubitril/valsartan enalapril pharmacoepidemiolgy mortality hospitalization
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fcvm.2020.602363/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!